Your Instrumentl Free Trial Request

No dark-mode styles — this email renders the same in a dark client.

Hi Emre,

Thank you for your interest in a free Instrumentl trial! We try our best to be truly helpful to nonprofits & grantwriters, so we suggest you have a strong grants strategy in place before investing time and resources in any tool.

We suggest you use Instrumentl when you or your clients are 501(c)(3) nonprofits in the United States.

Based on your signup responses, it sounds like you’re not in that category, so we haven’t activated your trial.

If this is a mistake, please respond to this email and let us know – we’ll be happy to set you up with a trial :) If helpful, you can also review this guide on grant-readiness[2].

And in case you’d find these helpful, here are our free grant writing resources you can explore next:
- Check out our blog: Get the best tips on grant writing, prospecting, tracking and management.
  - Subscribe[1] for new guides every week
  - Or start with our ultimate guide to check if your nonprofit is grant-ready[2]
- Download grant writing guides[3]: Get in-depth how-tos for mastering every stage of the grant lifecycle.
- Participate in a free grant writing class: Watch our free on-demand webinars[4] led by seasoned grant experts. Or join us live for our next grant writing workshops[5].

Too many resources on our blog that you don’t know where to start? Start here![6]

Again, please respond to this email with any questions – we’re here to help!

Best,

The Instrumentl Customer Success Team

P.S. If you are still working towards becoming grant-ready, please reach back out when we can be of help in the future. We’ll be happy to restart the conversation :)

[1] https://sgp.instrumentl.com/ls/click?upn=u001.2MgirwC-2B1PLHEquC2jVQXqEcCxWVA17JSXvAllatRseuDJFx-2F43IFmna08Op8z7lsWSFOwjytlbprjLbD79DIpsiNP2qan94ARf6U4lGE-2FpKkQ1ZAJyJNvN2uo1EFl-2FPBpIgrcH-2FEWt0z9jTgkra6-2BRjbySdFKCnwpyWyU8Su2g-3DKdwX_wFjO1XRUFFiq-2Bvj4C7JYHlbtuoGT6noIZPBXXOtv8EM-2FvOVjN7SCrdiksn-2FdYorFwTwMC6y-2FkJ0LdYHqWIy-2FoLY4vLtztSZkn96ffs-2BoA13nemKEPZy0kxrDoNOv4epfQlGZhM06rbiocnIP7Ia9F2wTn0BLABp9k0xL8-2B5i-2BAqNc686i-2FyEOGCTY8LCNtPAiNsi9Ws8OMLT-2FlFe8eufM5WYnymx7BZzLYi4NVWqx4-2FUrbNvP2Q4S0XVq9AdOLAuIcEg7qYTrvQKjJv2LiAWHw-3D-3D
[2] https://sgp.instrumentl.com/ls/click?upn=u001.2MgirwC-2B1PLHEquC2jVQXqEcCxWVA17JSXvAllatRscplS1NyGjvc-2BUb6RBk-2BnAFoem7mbXgLersDrlors84XjXDV5yf83l83XnOD-2FdkHIdvgcdgNgwT-2BgqoHeMXt-2FU98t-2BV7dV7zXteby3BNj1hKe7TFN4S-2BWzd4tHCtVW1brnEaa2Mr94gdcPYyNtRNedoOz6N_wFjO1XRUFFiq-2Bvj4C7JYHlbtuoGT6noIZPBXXOtv8EM-2FvOVjN7SCrdiksn-2FdYorFwTwMC6y-2FkJ0LdYHqWIy-2FoLY4vLtztSZkn96ffs-2BoA12NxElBe24d4pNmG-2BfAFejHw1TnpwtmCQdbb-2BxByMr1L-2Bbcfimq5pIsp-2B-2Ffyr9cbLaZWX918gSFpCJjhfjY9isQrLXgUKa0X0p7xa1gxeJCGZZb4dzJNfbFWtlkh2S1i2HNGh7FAjIYei19oZAFqP756vcSLjqvOgvaQSgebY4YaA-3D-3D
[3] https://sgp.instrumentl.com/ls/click?upn=u001.2MgirwC-2B1PLHEquC2jVQXqEcCxWVA17JSXvAllatRsfuys89UsHVKdwYWpBvSSo1g5qGZZUpgJklikgdcdVEaxiq-2BQA8sMN6Yew3iyYOFT1SbhIKOXAHstBDuaLSrH9NSxlALKqfkNryrIpm-2Bq3Wfg-3D-3Df9AY_wFjO1XRUFFiq-2Bvj4C7JYHlbtuoGT6noIZPBXXOtv8EM-2FvOVjN7SCrdiksn-2FdYorFwTwMC6y-2FkJ0LdYHqWIy-2FoLY4vLtztSZkn96ffs-2BoA12xPB5KiseqXTb2rVA7D2Dho7KaZISWwP0W-2BMm9umTsLkgdKeE3Tez5MV0uK-2BaZjKHDk3QXecpUvAGwxuQkByvT5JzSXRL7H1RwCODNhILb36zsj3yZbW1B5ikEBMqqbhHSbswhpcUedgRJwP97pG3MFWOh4UXq-2B6QEN6qTXxZK8Q-3D-3D
[4] https://sgp.instrumentl.com/ls/click?upn=u001.2MgirwC-2B1PLHEquC2jVQXqEcCxWVA17JSXvAllatRsefDYiC7PjxSe72jErv-2B07rac-2BA-2Fi0pPl3cUcges6uStj5B01gNiL3ASlQJX2G-2BLlbvJ7zJDQ5sBqbD8gBwIzrlT7MUcvlq0oUaXSPRGwMbSAMA1SFUWHQFVYhjb4cwt58Yfi8X-2BRNiFchh-2B1IXITX73hCP_wFjO1XRUFFiq-2Bvj4C7JYHlbtuoGT6noIZPBXXOtv8EM-2FvOVjN7SCrdiksn-2FdYorFwTwMC6y-2FkJ0LdYHqWIy-2FoLY4vLtztSZkn96ffs-2BoA10PqwkbQuGInnR1V9twRLWFHl10mcU4M8CWEXkz-2FgtBwS5azMX1vR-2BpkiQE1ifOUtfQMtyKQyQRDfNHamPb3ijT03kbkL6sqE7PB6SRkLg0djyHyAOrKyqTfujqc1G8Y9q6AUtcvWQXSjd6vCZLG2Bsy2BFni-2BQB8poGxr5iWTfzQ-3D-3D
[5] https://sgp.instrumentl.com/ls/click?upn=u001.2MgirwC-2B1PLHEquC2jVQXqEcCxWVA17JSXvAllatRsdqw8KTZiCk7ujD8v58sIXxkuxmP-2FlWCyuUWqQdP1Kml-2FNTm-2FsVYKnMstCjV12pGO5huRjVh17F-2BFAqv5BRYTNlqGrBwE0d0rexx0X6jgaztQ-3D-3D9Bqe_wFjO1XRUFFiq-2Bvj4C7JYHlbtuoGT6noIZPBXXOtv8EM-2FvOVjN7SCrdiksn-2FdYorFwTwMC6y-2FkJ0LdYHqWIy-2FoLY4vLtztSZkn96ffs-2BoA119lgVwzNmGGlOUkO2Vo5lPyGxq3hLONUnm7hyUvbfjqP6ubA2MtbJPoDxzdIBS3jJRhTWCvJKj-2Bava9YOsC1cOb-2B8bVjOWg4J0mkPzd8jm-2FTrZ9m1vwKCmotWHU0WnxS1lsvmUhucju12icfDrjnmFmywagvH8vehGKmPYN2LReg-3D-3D
[6] https://sgp.instrumentl.com/ls/click?upn=u001.2MgirwC-2B1PLHEquC2jVQXqEcCxWVA17JSXvAllatRseOSAcfOVVNIe9TlBvoMU-2FbUIxc9CjtsccyG-2BwKeAPU-2By5M6BQ04BdIK5ODXItbH4M1fkgdW93NjvE3i8sGhAnZss2jXlAxtd7i5KeiRoWxHEM5jNgHQpvJLced7oYwrPo-3DzOQG_wFjO1XRUFFiq-2Bvj4C7JYHlbtuoGT6noIZPBXXOtv8EM-2FvOVjN7SCrdiksn-2FdYorFwTwMC6y-2FkJ0LdYHqWIy-2FoLY4vLtztSZkn96ffs-2BoA13pAkAM6iaGPDSw6eVwCOTHWKdPE83YR77hFfwoxcw4LEAnkpwWx-2B6Kk4nIivYyPnUE0RWEZ9-2Fp4paerLe23nlp-2BZhn8htUHMW2T4PGLBif8gh9eSGxi33DrN33W5v-2BSGZP3GpfWHgQ-2BmXginD3Z-2FaneK0gRqH1EPg7fk7AnmlrCQ-3D-3D

Accession

nse/instrumentl/2026-11-10/6592

From

Instrumentl · hello@instrumentl.com

Sent

10 November 2026 · 20:00 UTC